These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 2919403)
1. Nafenopin, a peroxisome proliferator, depletes hepatic vitamin E content and elevates plasma oxidised glutathione levels in rats. Lake BG; Gray TJ; Körösi SA; Walters DG Toxicol Lett; 1989 Feb; 45(2-3):221-9. PubMed ID: 2919403 [TBL] [Abstract][Full Text] [Related]
2. Effects of the hepatocarcinogen nafenopin, a peroxisome proliferator, on the activities of rat liver glutathione-requiring enzymes and catalase in comparison to the action of phenobarbital. Furukawa K; Numoto S; Furuya K; Furukawa NT; Williams GM Cancer Res; 1985 Oct; 45(10):5011-9. PubMed ID: 2862989 [TBL] [Abstract][Full Text] [Related]
3. Role of fatty acyl coenzyme A oxidase in the efflux of oxidized glutathione from perfused livers of rats treated with the peroxisome proliferator nafenopin. Conway JG; Neptun DA; Garvey LK; Popp JA Cancer Res; 1987 Sep; 47(18):4795-800. PubMed ID: 3621175 [TBL] [Abstract][Full Text] [Related]
4. In vitro steady-state levels of hydrogen peroxide after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome proliferators. Tomaszewski KE; Agarwal DK; Melnick RL Carcinogenesis; 1986 Nov; 7(11):1871-6. PubMed ID: 3769136 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster. Lake BG; Evans JG; Cunninghame ME; Price RJ Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):241-7. PubMed ID: 8013414 [TBL] [Abstract][Full Text] [Related]
6. Long-term effects of hypolipidemic peroxisome proliferator administration on hepatic hydrogen peroxide metabolism in rats. Tamura H; Iida T; Watanabe T; Suga T Carcinogenesis; 1990 Mar; 11(3):445-50. PubMed ID: 2311188 [TBL] [Abstract][Full Text] [Related]
7. Stimulation of DNA synthesis but not of peroxisomal beta-oxidation by nafenopin in primary cultures of marmoset hepatocytes. Bieri F; Stäubli W; Waechter F; Muakkassah-Kelly S; Bentley P Cell Biol Int Rep; 1988 Dec; 12(12):1077-87. PubMed ID: 3147145 [TBL] [Abstract][Full Text] [Related]
8. Assessment of peroxisome proliferation and liver growth-stimulating potential by nondirectly genotoxic compounds in cultured hepatocytes. Bieri F; Stäubli W; Kelly S; Waechter F; Bentley P Mol Toxicol; 1987-1988 Fall; 1(4):439-44. PubMed ID: 3151502 [TBL] [Abstract][Full Text] [Related]
9. Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea pig, and marmoset. Lake BG; Evans JG; Gray TJ; Körösi SA; North CJ Toxicol Appl Pharmacol; 1989 Jun; 99(1):148-60. PubMed ID: 2499080 [TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferation and resistance to hydrogen peroxide in rat hepatocytes: is development of resistance an adaptation to cytotoxicity? Garberg P; Stenius U; Nilsson K; Högberg J Carcinogenesis; 1992 Oct; 13(10):1751-8. PubMed ID: 1423834 [TBL] [Abstract][Full Text] [Related]
11. Nafenopin-induced rat liver peroxisome proliferation reduces DNA methylation by N-nitrosodimethylamine in vivo. Wiestler OD; Schmerold I; Fringes B; Volk B; Kleihues P Carcinogenesis; 1985 Sep; 6(9):1309-13. PubMed ID: 4028330 [TBL] [Abstract][Full Text] [Related]
12. Induction of peroxisomal acyl CoA oxidase activity and lipid peroxidation in primary rat hepatocyte cultures. Tomaszewski KE; Heindel SW; Jenkins WL; Melnick RL Toxicology; 1990 Dec; 65(1-2):49-60. PubMed ID: 2274969 [TBL] [Abstract][Full Text] [Related]
13. Hepatic oxidative stress and related defenses during treatment of mice with acetylsalicylic acid and other peroxisome proliferators. Cai Y; Appelkvist EL; DePierre JW J Biochem Toxicol; 1995 Apr; 10(2):87-94. PubMed ID: 7562957 [TBL] [Abstract][Full Text] [Related]
14. Use of primary cultures of adult rat hepatocytes to investigate mechanisms of action of nafenopin, a hepatocarcinogenic peroxisome proliferator. Bieri F; Bentley P; Waechter F; Stäubli W Carcinogenesis; 1984 Aug; 5(8):1033-9. PubMed ID: 6146407 [TBL] [Abstract][Full Text] [Related]
15. Investigations on the mechanism of liver tumour induction by peroxisome proliferators. Bentley P; Bieri F; Mitchell F; Waechter F; Stäubli W Arch Toxicol Suppl; 1987; 10():157-61. PubMed ID: 3495251 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of nafenopin on hepatic peroxisome proliferation and replicative DNA synthesis in the rat and Syrian hamster. Price RJ; Evans JG; Lake BG Food Chem Toxicol; 1992 Nov; 30(11):937-44. PubMed ID: 1473786 [TBL] [Abstract][Full Text] [Related]
17. Nafenopin-induced peroxisome proliferation in vitamin A deficient rats. Lawrence JW; Foxworthy PS; Perry DN; Jensen CB; Giera DD; Meador VP; Eacho PI Biochem Pharmacol; 1995 Mar; 49(7):915-9. PubMed ID: 7741763 [TBL] [Abstract][Full Text] [Related]
18. Inhibition instead of enhancement of lipid peroxidation by pretreatment with the carcinogenic peroxisome proliferator nafenopin in rat liver exposed to a high single dose of corn oil. Huber WW; Grasl-Kraupp B; Stekel H; Gschwentner C; Lang H; Schulte-Hermann R Arch Toxicol; 1997; 71(9):575-81. PubMed ID: 9285040 [TBL] [Abstract][Full Text] [Related]
19. Effects of the hepatocarcinogenic peroxisome-proliferating hypolipidemic agents clofibrate and nafenopin on the rat liver cell membrane enzymes gamma-glutamyltranspeptidase and alkaline phosphatase and on the early stages of liver carcinogenesis. Numoto S; Furukawa K; Furuya K; Williams GM Carcinogenesis; 1984 Dec; 5(12):1603-11. PubMed ID: 6149819 [TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator nafenopin potentiated cytotoxicity and genotoxicity of cyclophosphamide in the liver and bone marrow cells. Voskoboinik I; Drew R; Ahokas JT Chem Biol Interact; 1997 Jul; 105(2):81-97. PubMed ID: 9251722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]